Follow The Filings

ICU SeaStar Medical

SeaStar Medical earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ICU's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ICU insider trades
  • $8,538 bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Michael Messinger CFO
    Buy
    $2,453 750 shares at $3.27 +43% to stake
    Traded Aug 18 Filed Aug 19
  2. Jennifer A Baird Director
    Buy
    $987 4,200 shares at $0.2400 +13% to stake
    Traded Dec 19, 2025 Filed Dec 22, 2025
  3. Michael Messinger CFO
    Buy
    $5,098 14,500 shares at $0.3500 +483% to stake
    Traded Dec 9, 2025 Filed Dec 11, 2025

Also filed in the last 12 months, not counted as buying or selling: 13 stock grants.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
8-K 1.01,3.02,8.01,9.01
8-K 2.02,9.01
10-Q FORM 10-Q
8-K 5.02
8-K/A 5.02
8-K 5.02,5.07,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q FORM 10-Q
424B3 PROSPECTUS
SCHEDULE 13G —
S-1/A AMENDMENT NO. 1 TO FORM S-1
DEF 14A FORM DEF 14A
8-K 8.01
S-1 REGISTRATION STATEMENT
8-K 2.02,9.01
10-K FORM 10-K
SCHEDULE 13G/A —
8-K 8.01
8-K/A 3.03,8.01,9.01
8-K 3.03,5.07
424B5 FORM 424B5
8-K 5.02
DEF 14A PROXY STATEMENT

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.